Igarashi Kentaro相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Ultra-low Concentrations of Cisplatinum Down to the IC(10) in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo

超低浓度顺铂（低至IC(10)）与重组甲硫氨酸酶联合使用，在体外和体内均对肺癌细胞具有协同作用。

影响因子:1.8

doi:10.21873/invivo.14238

Asano, Yohei; Han, Qinghong; Li, Shukuan; Kang, Byung Mo; Kim, Jin Soo; Miyashi, Yuta; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Morinaga, Sei; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

细胞生物学

发表日期：2026

文献求助收藏

Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression

经筛选获得超高阿霉素耐药性的人类纤维肉瘤细胞，获得了曲贝替定交叉耐药性，对重组甲硫氨酸酶仍然敏感，并且c-MYC表达增加。

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1704021

Morinaga, Sei; Han, Qinghong; Mizuta, Kohei; Kang, Byung Mo; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

细胞生物学

发表日期：2025

文献求助收藏

The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo

肿瘤靶向沙门氏菌A1-R与自噬抑制剂氯喹联合使用，可在体外和体内协同根除HT1080纤维肉瘤细胞

影响因子:1.8

doi:10.21873/invivo.13807

Morinaga, Sei; Zhao, Ming; Mizuta, Kohei; Kang, Byung Mo; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

细胞生物学

发表日期：2025

文献求助收藏

Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models

在裸鼠模型中，采用甲硫氨酸限制联合异环磷酰胺治疗获得性异环磷酰胺耐药的纤维肉瘤可实现协同根除。

影响因子:1.8

doi:10.21873/invivo.13809

Morinaga, Sei; Han, Qinghong; Mizuta, Kohei; Kang, Byung Mo; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

发表日期：2025

文献求助收藏

Dynamic Fluorescence Imaging of Orally-administered Tumor-targeting Salmonella typhimurium A1-R Expressing Green Fluorescent Protein Trafficking Through the Gastrointestinal System to Target Fibrosarcomas in Nude Mice

利用动态荧光成像技术研究口服表达绿色荧光蛋白的靶向肿瘤的鼠伤寒沙门氏菌A1-R菌株在裸鼠胃肠道系统中转运并靶向治疗纤维肉瘤的过程

影响因子:1.8

doi:10.21873/invivo.13869

Morinaga, Sei; Zhao, Ming; Mizuta, Kohei; Kang, Byung Mo; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

发表日期：2025

文献求助收藏

HT1080 Fibrosarcoma With Acquired Trabectedin Resistance: Increased Malignancy But Sustained Sensitivity to Methionine Restriction

HT1080 纤维肉瘤获得性曲贝替定耐药：恶性程度增加但对蛋氨酸限制仍保持敏感性

影响因子:1.8

doi:10.21873/invivo.13872

Morinaga, Sei; Han, Qinghong; Mizuta, Kohei; Kang, Byung Mo; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

发表日期：2025

文献求助收藏

HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice

体外筛选出的具有超强艾立布林抗性的HT1080人纤维肉瘤细胞恶性程度更高，并且在裸鼠体内，甲硫氨酸限制与艾立布林联合使用可协同抑制其恶性生长。

影响因子:1.8

doi:10.21873/invivo.13931

Morinaga, Sei; Mizuta, Kohei; Kang, Byung Mo; Han, Qinghong; Bouvet, Michael; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

细胞生物学

发表日期：2025

文献求助收藏

Limited predictive value of pretreatment P-glycoprotein immunostaining for chemotherapy efficacy and survival in long-follow-up osteosarcoma patients

治疗前P-糖蛋白免疫染色对骨肉瘤患者长期随访中化疗疗效和生存率的预测价值有限

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000043472

Higuchi, Takashi; Igarashi, Kentaro; Miwa, Shinji; Takeuchi, Akihiko; Hayashi, Katsuhiro; Demura, Satoru; Yamamoto, Norio; Tsuchiya, Hiroyuki

免疫/内分泌

发表日期：2025

文献求助收藏

Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy

既往进展的慢性淋巴细胞白血病 (CLL) 患者接受蛋氨酸限制联合一线化疗后达到完全缓解 (CR)

doi:10.21873/cdp.10407

Morinaga, Sei; Han, Qinghong; Mizuta, Kohei; Kang, Byung Mo; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

细胞生物学

发表日期：2025

文献求助收藏

Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)

腹膜转移瘤创新治疗策略展望：包括腹膜切除术、腹腔热灌注化疗和辅助化疗，组织培养药物反应试验（HDRA）证实其疗效

doi:10.21873/cdp.10440

Asano, Yohei; Yonemura, Yutaka; Hozumi, Chihiro; Mizuta, Kohei; Kang, Byung Mo; Kim, Jin Soo; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Higuchi, Takashi; Morinaga, Sei; Tsuchiya, Hiroyuki; Demura, Satoru; Hoffman, Robert M

发表日期：2025

文献求助收藏